Stacey W. Martin

Best Publications

• Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

  Carlos G Grijalva;J Pekka Nuorti;Patrick G Arbogast;Stacey W Martin

  895
  Citations

• Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

  T.T. Shimabukuro;S.Y. Kim;T.R. Myers;P.L. Moro

  890
  Citations

• COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021

  Unknown

  457
  Citations

• First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.

  Julianne Gee;Paige Marquez;John Su;Geoffrey M. Calvert

  402
  Citations

• Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016

  Unknown

  316
  Citations

• National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States

  Carlos G. Grijalva;Katherine A. Poehling;J. Pekka Nuorti;Yuwei Zhu

  297
  Citations

• Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010

  Lara K. Misegades;Kathleen Winter;Kathleen Harriman;John Talarico

  291
  Citations

• Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity

  Paul A. Kristiansen;Fabien Diomandé;Absatou Ky Ba;Idrissa Sanou

  284
  Citations

• Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy — U.S. Territories, January 1, 2016–April 25, 2017

  Unknown

  281
  Citations

• Waning Immunity to Pertussis Following 5 Doses of DTaP

  Sara Y Tartof;Melissa Lewis;Cynthia Kenyon;Karen White

  271
  Citations

• Reduction of Frequent Otitis Media and Pressure-Equalizing Tube Insertions in Children After Introduction of Pneumococcal Conjugate Vaccine

  Katherine A. Poehling;Peter G. Szilagyi;Carlos G. Grijalva;Stacey W. Martin

  257
  Citations

• Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.

  Unknown

  256
  Citations

• Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015.

  Unknown

  240
  Citations

• Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage

  Unknown

  229
  Citations

• Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

  Ryan T Novak;Jean Ludovic Kambou;Fabien V K Diomandé;Tiga F Tarbangdo

  202
  Citations

• Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.

  Tami H Skoff;Amy E Blain;James Watt;Karen Scherzinger

  199
  Citations

• Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis

  Henry M. Wu;Soraia M. Cordeiro;Brian H. Harcourt;Maria da Gloria S. Carvalho

  182
  Citations

• Sources of Infant Pertussis Infection in the United States

  Unknown

  180
  Citations

• Epidemiologic and Laboratory Features of a Large Outbreak of Pertussis-Like Illnesses Associated With Cocirculating Bordetella holmesii and Bordetella pertussis—Ohio, 2010–2011

  Unknown

  176
  Citations

• Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.

  Titilope Oduyebo;Kara D Polen;Henry T Walke;Sarah Reagan-Steiner

  170
  Citations